Rubella

Pregnant women with known exposure to rubella who are susceptible to rubella or who have uncertain immunity (no or unknown immunization history and no previous serologic testing), whether or not they are symptomatic, should be referred to a high-risk perinatal specialist and a pediatric infectious disease specialist to evaluate the likelihood of fetal infection and risk of sequelae.

Tratamento adicional recomendado para ALGUNS pacientes no grupo de pacientes selecionado

High dose polyclonal immune globulin may be of benefit for preventing clinical rubella but is not routinely recommended for this purpose because there is insufficient evidence for prevention of congenital rubella in the fetus.[45]Young MK, Cripps AW, Nimmo GR, et al. Post-exposure passive immunisation for preventing rubella and congenital rubella syndrome. Cochrane Database Syst Rev. 2015 Sep 9;(9):CD010586. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010586.pub2/full http://www.ncbi.nlm.nih.gov/pubmed/26350479?tool=bestpractice.com ​ This option may be considered for post-exposure prophylaxis.​

Postnatal rubella is generally a mild, self-limited condition that requires only symptomatic therapy. No specific antiviral therapy is available. A brief course of an NSAID, if no contraindication exists, may be helpful for patients with arthritis.